Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCA | P06881 | 2/20 | 0.69 |
| ▸ | NPY1R | P25929 | 1/20 | 0.69 |
| ▸ | NPY2R | P49146 | 1/20 | 0.69 |
| ▸ | NPY4R | P50391 | 1/20 | 0.69 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.69 |
| ▸ | CXCR4 | P61073 | 7/20 | 0.67 |
| ▸ | GLP1R | P43220 | 6/20 | 0.65 |
| ▸ | GRPR | P30550 | 2/20 | 0.65 |
| ▸ | GCGR | P47871 | 3/20 | 0.64 |
| ▸ | MC4R | P32245 | 1/20 | 0.64 |
| ▸ | MC5R | P33032 | 1/20 | 0.64 |
| ▸ | MC3R | P41968 | 1/20 | 0.64 |
| ▸ | MC1R | Q01726 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29366899 | 0.94 | GLP1R (0.70) | CALCANPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL31083828 | 0.94 | GLP1R (0.70) | CALCANPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL29351953 | 0.93 | NPY2R (0.74) | CALCANPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL31720568 | 0.92 | GRPR (0.70) | CALCANPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL29464570 | 0.89 | NPY2R (0.71) | CALCANPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL29462210 | 0.89 | NMBR (0.77) | GLP1RGRPRGCGR | |
| SCHEMBL29355231 | 0.87 | NPY1R (0.76) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL23273229 | 0.87 | NMBR (0.69) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| Water SCHEMBL29941416 | 0.86 | NPY1R (0.75) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL31060386 | 0.86 | CALCA (0.75) | CALCANPY1RNPY2RNPY4RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE49961-E1 | Solid phase peptide syntheses | CEM CORPORATION (US) | 2024-05-07 | — | — | US | disclosed |
| EP-3507299-B1 | IN-SITU SOLVENT RECYCLING PROCESS FOR SOLID PHASE PEPTIDE SYNTHESIS AT ELEVATED TEMPERATURES | CEM CORP (US) | 2022-07-27 | — | — | EP | disclosed |
| CN-109311910-B | Tacrolimus conjugates, compositions thereof, and uses thereof | 杜兰教育基金委员会 | 2022-02-01 | — | — | CN | disclosed |